Related Experiment Video

Updated: May 5, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

11.4K

Human papillomavirus vaccine in patients with systemic lupus erythematosus

Paolo Pellegrino1, Carla Carnovale, Valentina Perrone

  • 1Unit of Clinical Pharmacology, University Hospital "Luigi Sacco", Università di Milano, Milan, Italy IRCCS Foundation, Ca' Granda Ospedale, Maggiore Policlinico, Milan, Italy Scientific Institute, IRCCS E. Medea, Bosisio Parini, Lecco, Italy Unit of Clinical Pharmacology, University Hospital "Luigi Sacco", Università di Milano, Milan, Italy, sonia.radice@unimi.it.

Epidemiology (Cambridge, Mass.)
|December 4, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.7K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

29.0K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K